These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10370216)

  • 1. Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using two media, DMEMc and HBSS.
    Mathieu F; Galmier MJ; Pognat JF; Petit J; Lartigue C
    Int J Pharm; 1999 Apr; 181(2):203-17. PubMed ID: 10370216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using a "dynamic model".
    Mathieu F; Galmier MJ; Nicolay A; Pognat JF; Lartigue C
    Eur J Drug Metab Pharmacokinet; 2003; 28(2):155-60. PubMed ID: 12877575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or "TEER, a measurement of toxicity?".
    Mathieu F; Galmier MJ; Pognat JF; Lartigue C
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):85-90. PubMed ID: 16010866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dulbecco's modified eagle's medium and minimum essential medium--which one is more preferred for establishment of Caco-2 cell monolayer model used in evaluation of drug absorption?
    Wu XW; Wang RF; Yuan M; Xu W; Yang XW
    Pharmazie; 2013 Oct; 68(10):805-10. PubMed ID: 24273884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms.
    Lind ML; Jacobsen J; Holm R; Müllertz A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):261-70. PubMed ID: 17890067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial properties of human intestinal Caco-2 cells cultured in a serum-free medium.
    Hashimoto K; Shimizu M
    Cytotechnology; 1993; 13(3):175-84. PubMed ID: 7764660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.
    Tamura K; Lee CP; Smith PL; Borchardt RT
    Pharm Res; 1996 Nov; 13(11):1663-7. PubMed ID: 8956331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium glycocholate transport across Caco-2 cell monolayers, and the enhancement of mannitol transport relative to transepithelial electrical resistance.
    Lindhardt K; Bechgaard E
    Int J Pharm; 2003 Feb; 252(1-2):181-6. PubMed ID: 12550793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.
    Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M
    J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages increase microparticle uptake by enterocyte-like Caco-2 cell monolayers.
    Moyes SM; Morris JF; Carr KE
    J Anat; 2010 Dec; 217(6):740-54. PubMed ID: 20880316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
    Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
    Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inter-laboratory study to evaluate the effects of medium composition on the differentiation and barrier function of Caco-2 cell lines.
    Zucco F; Batto AF; Bises G; Chambaz J; Chiusolo A; Consalvo R; Cross H; Dal Negro G; de Angelis I; Fabre G; Guillou F; Hoffman S; Laplanche L; Morel E; Pinçon-Raymond M; Prieto P; Turco L; Ranaldi G; Rousset M; Sambuy Y; Scarino ML; Torreilles F; Stammati A
    Altern Lab Anim; 2005 Dec; 33(6):603-18. PubMed ID: 16372835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption properties of micellar lipid metabolites into Caco2 cells.
    Tsuzuki W
    Lipids; 2007 Jul; 42(7):613-9. PubMed ID: 17582542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
    Liu DZ; LeCluyse EL; Thakker DR
    J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the biotransformation of bepridil analogs in isolated liver cells from one rat. Relationships between structure and in vitro liver toxicity.
    Damatte E; Galmier MJ; Lartigue-Mattei C; Pognat JF; Busch N; Chabard JL
    Eur J Drug Metab Pharmacokinet; 1996; 21(4):315-25. PubMed ID: 9074896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport.
    Leonard M; Creed E; Brayden D; Baird AW
    Pharm Res; 2000 Oct; 17(10):1181-8. PubMed ID: 11145222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and better protocols for a short-term Caco-2 cell culture system.
    Yamashita S; Konishi K; Yamazaki Y; Taki Y; Sakane T; Sezaki H; Furuyama Y
    J Pharm Sci; 2002 Mar; 91(3):669-79. PubMed ID: 11920752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulated intestinal fluid as transport medium in the Caco-2 cell culture model.
    Ingels F; Deferme S; Destexhe E; Oth M; Van den Mooter G; Augustijns P
    Int J Pharm; 2002 Jan; 232(1-2):183-92. PubMed ID: 11790502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell.
    Mukherjee T; Squillantea E; Gillespieb M; Shao J
    Drug Deliv; 2004; 11(1):11-8. PubMed ID: 15168786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
    Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
    Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.